ID   MKKS_HUMAN              Reviewed;         570 AA.
AC   Q9NPJ1; A8K7B0; D3DW18;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-JUN-2023, entry version 196.
DE   RecName: Full=Molecular chaperone MKKS {ECO:0000305};
DE   AltName: Full=Bardet-Biedl syndrome 6 protein;
DE   AltName: Full=McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin;
GN   Name=MKKS {ECO:0000312|HGNC:HGNC:7108};
GN   Synonyms=BBS6 {ECO:0000303|PubMed:28753627};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS MKKS CYS-37; TYR-84 AND SER-242, AND
RP   VARIANTS VAL-49 AND CYS-517.
RX   PubMed=10802661; DOI=10.1038/75637;
RA   Stone D.L., Slavotinek A.M., Bouffard G.G., Banerjee-Basu S.,
RA   Baxevanis A.D., Barr M., Biesecker L.G.;
RT   "Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman
RT   syndrome.";
RL   Nat. Genet. 25:79-82(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANTS BBS6 ASP-52; LEU-155;
RP   ALA-286; GLU-345 AND SER-499, AND CHARACTERIZATION OF VARIANT PRO-325.
RX   PubMed=15731008; DOI=10.1242/jcs.01676;
RA   Kim J.C., Ou Y.Y., Badano J.L., Esmail M.A., Leitch C.C., Fiedrich E.,
RA   Beales P.L., Archibald J.M., Katsanis N., Rattner J.B., Leroux M.R.;
RT   "MKKS/BBS6, a divergent chaperonin-like protein linked to the obesity
RT   disorder Bardet-Biedl syndrome, is a novel centrosomal component required
RT   for cytokinesis.";
RL   J. Cell Sci. 118:1007-1020(2005).
RN   [7]
RP   INTERACTION WITH CCDC28B.
RX   PubMed=16327777; DOI=10.1038/nature04370;
RA   Badano J.L., Leitch C.C., Ansley S.J., May-Simera H., Lawson S.,
RA   Lewis R.A., Beales P.L., Dietz H.C., Fisher S., Katsanis N.;
RT   "Dissection of epistasis in oligogenic Bardet-Biedl syndrome.";
RL   Nature 439:326-330(2006).
RN   [8]
RP   SUBCELLULAR LOCATION, INTERACTION WITH STUB1, AND CHARACTERIZATION OF
RP   VARIANTS BBS6 CYS-37; ALA-57; SER-242; GLU-345 AND SER-499.
RX   PubMed=18094050; DOI=10.1091/mbc.e07-07-0631;
RA   Hirayama S., Yamazaki Y., Kitamura A., Oda Y., Morito D., Okawa K.,
RA   Kimura H., Cyr D.M., Kubota H., Nagata K.;
RT   "MKKS is a centrosome-shuttling protein degraded by disease-causing
RT   mutations via CHIP-mediated ubiquitination.";
RL   Mol. Biol. Cell 19:899-911(2008).
RN   [9]
RP   FUNCTION, IDENTIFICATION IN A MULTIPROTEIN COMPLEX, INTERACTION WITH BBS2,
RP   AND CHARACTERIZATION OF VARIANTS BBS6 CYS-37; ASP-52; ALA-57; TYR-84;
RP   PRO-236 AND PRO-277.
RX   PubMed=20080638; DOI=10.1073/pnas.0910268107;
RA   Seo S., Baye L.M., Schulz N.P., Beck J.S., Zhang Q., Slusarski D.C.,
RA   Sheffield V.C.;
RT   "BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and
RT   mediate BBSome assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:1488-1493(2010).
RN   [10]
RP   INTERACTION WITH BBS12, VARIANT BBS6 ARG-395, AND CHARACTERIZATION OF
RP   VARIANT BBS6 ARG-395.
RX   PubMed=26900326;
RA   Hulleman J.D., Nguyen A., Ramprasad V.L., Murugan S., Gupta R.,
RA   Mahindrakar A., Angara R., Sankurathri C., Mootha V.V.;
RT   "A novel H395R mutation in MKKS/BBS6 causes retinitis pigmentosa and
RT   polydactyly without other findings of Bardet-Biedl or McKusick-Kaufman
RT   syndrome.";
RL   Mol. Vis. 22:73-81(2016).
RN   [11]
RP   INTERACTION WITH DLEC1.
RX   PubMed=33144677; DOI=10.1038/s41598-020-75957-y;
RA   Okitsu Y., Nagano M., Yamagata T., Ito C., Toshimori K., Dohra H.,
RA   Fujii W., Yogo K.;
RT   "Dlec1 is required for spermatogenesis and male fertility in mice.";
RL   Sci. Rep. 10:18883-18883(2020).
RN   [12]
RP   VARIANT BBS6 ASP-52.
RX   PubMed=10973238; DOI=10.1038/79116;
RA   Slavotinek A.M., Stone E.M., Mykytyn K., Heckenlively J.R., Green J.S.,
RA   Heon E., Musarella M.A., Parfrey P.S., Sheffield V.C., Biesecker L.G.;
RT   "Mutations in MKKS cause Bardet-Biedl syndrome.";
RL   Nat. Genet. 26:15-16(2000).
RN   [13]
RP   VARIANTS BBS6 CYS-37; ALA-57 AND PRO-277.
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=10973251; DOI=10.1038/79201;
RA   Katsanis N., Beales P.L., Woods M.O., Lewis R.A., Green J.S., Parfrey P.S.,
RA   Ansley S.J., Davidson W.S., Lupski J.R.;
RT   "Mutations in MKKS cause obesity, retinal dystrophy and renal malformations
RT   associated with Bardet-Biedl syndrome.";
RL   Nat. Genet. 26:67-70(2000).
RN   [14]
RP   VARIANTS BBS6 MET-32; ALA-57; PRO-236; ALA-286; SER-499; ALA-511 AND
RP   HIS-518, AND VARIANT SER-242.
RX   PubMed=11179009; DOI=10.1086/318794;
RA   Beales P.L., Katsanis N., Lewis R.A., Ansley S.J., Elcioglu N., Raza J.,
RA   Woods M.O., Green J.S., Parfrey P.S., Davidson W.S., Lupski J.R.;
RT   "Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort
RT   reveal a minor involvement of BBS6 and delineate the critical intervals of
RT   other loci.";
RL   Am. J. Hum. Genet. 68:606-616(2001).
RN   [15]
RP   VARIANTS BBS6 CYS-37; SER-242 AND SER-499.
RX   PubMed=11567139; DOI=10.1126/science.1063525;
RA   Katsanis N., Ansley S.J., Badano J.L., Eichers E.R., Lewis R.A.,
RA   Hoskins B.E., Scambler P.J., Davidson W.S., Beales P.L., Lupski J.R.;
RT   "Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive
RT   disorder.";
RL   Science 293:2256-2259(2001).
RN   [16]
RP   VARIANTS BBS6 LEU-155; SER-242 AND GLU-345, AND VARIANT VAL-339.
RX   PubMed=12107442; DOI=10.1007/s00439-002-0733-3;
RA   Slavotinek A.M., Searby C., Al-Gazali L., Hennekam R.C.M.,
RA   Schrander-Stumpel C., Orcana-Losa M., Pardo-Reoyo S., Cantani A., Kumar D.,
RA   Capellini Q., Neri G., Zackai E., Biesecker L.G.;
RT   "Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and
RT   selected Bardet-Biedl syndrome patients.";
RL   Hum. Genet. 110:561-567(2002).
RN   [17]
RP   VARIANT BBS6 PRO-236, AND VARIANT PRO-325.
RX   PubMed=12677556; DOI=10.1086/375178;
RA   Beales P.L., Badano J.L., Ross A.J., Ansley S.J., Hoskins B.E., Kirsten B.,
RA   Mein C.A., Froguel P., Scambler P.J., Lewis R.A., Lupski J.R., Katsanis N.;
RT   "Genetic interaction of BBS1 mutations with alleles at other BBS loci can
RT   result in non-Mendelian Bardet-Biedl syndrome.";
RL   Am. J. Hum. Genet. 72:1187-1199(2003).
RN   [18]
RP   VARIANT PRO-325, AND CHARACTERIZATION OF VARIANT PRO-325.
RX   PubMed=12837689; DOI=10.1093/hmg/ddg188;
RA   Badano J.L., Kim J.C., Hoskins B.E., Lewis R.A., Ansley S.J., Cutler D.J.,
RA   Castellan C., Beales P.L., Leroux M.R., Katsanis N.;
RT   "Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic
RT   effect on Bardet-Biedl patients with two mutations at a second BBS locus.";
RL   Hum. Mol. Genet. 12:1651-1659(2003).
RN   [19]
RP   VARIANTS BBS6 PRO-181 AND ASN-492.
RX   PubMed=12920096; DOI=10.1136/jmg.40.8.e104;
RA   Fauser S., Munz M., Besch D.;
RT   "Further support for digenic inheritance in Bardet-Biedl syndrome.";
RL   J. Med. Genet. 40:E104-E104(2003).
RN   [20]
RP   VARIANTS BBS6 PRO-237 AND PRO-460, AND VARIANTS VAL-339; CYS-517 AND
RP   VAL-532.
RX   PubMed=15666242; DOI=10.1086/428679;
RA   Karmous-Benailly H., Martinovic J., Gubler M.-C., Sirot Y., Clech L.,
RA   Ozilou C., Auge J., Brahimi N., Etchevers H., Detrait E., Esculpavit C.,
RA   Audollent S., Goudefroye G., Gonzales M., Tantau J., Loget P., Joubert M.,
RA   Gaillard D., Jeanne-Pasquier C., Delezoide A.-L., Peter M.-O., Plessis G.,
RA   Simon-Bouy B., Dollfus H., Le Merrer M., Munnich A., Encha-Razavi F.,
RA   Vekemans M., Attie-Bitach T.;
RT   "Antenatal presentation of Bardet-Biedl syndrome may mimic Meckel
RT   syndrome.";
RL   Am. J. Hum. Genet. 76:493-504(2005).
RN   [21]
RP   VARIANTS BBS6 ALA-237 AND PRO-237, AND VARIANTS VAL-339; CYS-517 AND
RP   VAL-532.
RX   PubMed=15770229; DOI=10.1038/sj.ejhg.5201372;
RA   Hichri H., Stoetzel C., Laurier V., Caron S., Sigaudy S., Sarda P.,
RA   Hamel C., Martin-Coignard D., Gilles M., Leheup B., Holder M., Kaplan J.,
RA   Bitoun P., Lacombe D., Verloes A., Bonneau D., Perrin-Schmitt F.,
RA   Brandt C., Besancon A.-F., Mandel J.-L., Cossee M., Dollfus H.;
RT   "Testing for triallelism: analysis of six BBS genes in a Bardet-Biedl
RT   syndrome family cohort.";
RL   Eur. J. Hum. Genet. 13:607-616(2005).
RN   [22]
RP   VARIANTS SER-242; CYS-517 AND VAL-532.
RX   PubMed=15483080; DOI=10.1210/jc.2004-0465;
RA   Andersen K.L., Echwald S.M., Larsen L.H., Hamid Y.H., Glumer C.,
RA   Jorgensen T., Borch-Johnsen K., Andersen T., Sorensen T.I., Hansen T.,
RA   Pedersen O.;
RT   "Variation of the McKusick-Kaufman gene and studies of relationships with
RT   common forms of obesity.";
RL   J. Clin. Endocrinol. Metab. 90:225-230(2005).
RN   [23]
RP   VARIANT SER-242, AND DISCUSSION OF THE PATHOLOGICAL ROLE OF VARIANT
RP   SER-242.
RX   PubMed=20120035; DOI=10.1002/humu.21204;
RA   Hjortshoj T.D., Gronskov K., Philp A.R., Nishimura D.Y., Riise R.,
RA   Sheffield V.C., Rosenberg T., Brondum-Nielsen K.;
RT   "Bardet-Biedl syndrome in Denmark -- report of 13 novel sequence variations
RT   in six genes.";
RL   Hum. Mutat. 31:429-436(2010).
RN   [24]
RP   VARIANTS BBS6 ARG-41; ARG-99 AND LEU-299, AND VARIANT THR-488.
RX   PubMed=21344540; DOI=10.1002/humu.21480;
RA   Deveault C., Billingsley G., Duncan J.L., Bin J., Theal R., Vincent A.,
RA   Fieggen K.J., Gerth C., Noordeh N., Traboulsi E.I., Fishman G.A.,
RA   Chitayat D., Knueppel T., Millan J.M., Munier F.L., Kennedy D.,
RA   Jacobson S.G., Innes A.M., Mitchell G.A., Boycott K., Heon E.;
RT   "BBS genotype-phenotype assessment of a multiethnic patient cohort calls
RT   for a revision of the disease definition.";
RL   Hum. Mutat. 32:610-619(2011).
RN   [25]
RP   VARIANT BBS6 ALA-57.
RX   PubMed=22152675; DOI=10.1016/j.ajhg.2011.11.005;
RA   Huang L., Szymanska K., Jensen V.L., Janecke A.R., Innes A.M., Davis E.E.,
RA   Frosk P., Li C., Willer J.R., Chodirker B.N., Greenberg C.R., McLeod D.R.,
RA   Bernier F.P., Chudley A.E., Muller T., Shboul M., Logan C.V., Loucks C.M.,
RA   Beaulieu C.L., Bowie R.V., Bell S.M., Adkins J., Zuniga F.I., Ross K.D.,
RA   Wang J., Ban M.R., Becker C., Nurnberg P., Douglas S., Craft C.M.,
RA   Akimenko M.A., Hegele R.A., Ober C., Utermann G., Bolz H.J., Bulman D.E.,
RA   Katsanis N., Blacque O.E., Doherty D., Parboosingh J.S., Leroux M.R.,
RA   Johnson C.A., Boycott K.M.;
RT   "TMEM237 is mutated in individuals with a Joubert syndrome related disorder
RT   and expands the role of the TMEM family at the ciliary transition zone.";
RL   Am. J. Hum. Genet. 89:713-730(2011).
RN   [26]
RP   VARIANT BBS6 40-SER--ASN-570 DEL.
RX   PubMed=28761321;
RA   Ullah A., Umair M., Yousaf M., Khan S.A., Nazim-Ud-Din M., Shah K.,
RA   Ahmad F., Azeem Z., Ali G., Alhaddad B., Rafique A., Jan A., Haack T.B.,
RA   Strom T.M., Meitinger T., Ghous T., Ahmad W.;
RT   "Sequence variants in four genes underlying Bardet-Biedl syndrome in
RT   consanguineous families.";
RL   Mol. Vis. 23:482-494(2017).
RN   [27]
RP   CHARACTERIZATION OF VARIANTS MKKS CYS-37; TYR-84 AND SER-242, SUBCELLULAR
RP   LOCATION, FUNCTION, MUTAGENESIS OF LEU-454, CHARACTERIZATION OF VARIANT
RP   BBS6 CYS-37, AND INTERACTION WITH SMARCC1.
RX   PubMed=28753627; DOI=10.1371/journal.pgen.1006936;
RA   Scott C.A., Marsden A.N., Rebagliati M.R., Zhang Q., Chamling X.,
RA   Searby C.C., Baye L.M., Sheffield V.C., Slusarski D.C.;
RT   "Nuclear/cytoplasmic transport defects in BBS6 underlie congenital heart
RT   disease through perturbation of a chromatin remodeling protein.";
RL   PLoS Genet. 13:E1006936-E1006936(2017).
CC   -!- FUNCTION: Probable molecular chaperone that assists the folding of
CC       proteins upon ATP hydrolysis (PubMed:20080638). Plays a role in the
CC       assembly of BBSome, a complex involved in ciliogenesis regulating
CC       transports vesicles to the cilia (PubMed:20080638). May play a role in
CC       protein processing in limb, cardiac and reproductive system
CC       development. May play a role in cytokinesis (PubMed:28753627).
CC       {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:28753627}.
CC   -!- SUBUNIT: Component of a complex composed at least of MKKS, BBS10,
CC       BBS12, TCP1, CCT2, CCT3, CCT4, CCT5 and CCT8 (PubMed:20080638).
CC       Interacts with STUB1 (PubMed:18094050). Interacts with BBS2 (via coiled
CC       coil domain) (PubMed:20080638). Interacts with CCDC28B
CC       (PubMed:16327777). Interacts with BBS12 (PubMed:26900326). Interacts
CC       with SMARCC1, a component of the SWI/SNF complexes; the interaction
CC       takes place predominantly in the cytoplasm and may modulate SMARCC1
CC       location (PubMed:28753627). Interacts with DLEC1 (PubMed:33144677).
CC       {ECO:0000269|PubMed:16327777, ECO:0000269|PubMed:18094050,
CC       ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:26900326,
CC       ECO:0000269|PubMed:28753627, ECO:0000269|PubMed:33144677}.
CC   -!- INTERACTION:
CC       Q9NPJ1; Q6ZW61: BBS12; NbExp=14; IntAct=EBI-721319, EBI-6128352;
CC       Q9NPJ1; Q9BXC9: BBS2; NbExp=4; IntAct=EBI-721319, EBI-748297;
CC       Q9NPJ1; Q01850: CDR2; NbExp=3; IntAct=EBI-721319, EBI-1181367;
CC       Q9NPJ1; O96006: ZBED1; NbExp=3; IntAct=EBI-721319, EBI-740037;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome. Cytoplasm, cytosol {ECO:0000269|PubMed:28753627}.
CC       Nucleus {ECO:0000269|PubMed:28753627}. Note=The majority of the protein
CC       resides within the pericentriolar material (PCM), a proteinaceous tube
CC       surrounding centrioles. During interphase, the protein is confined to
CC       the lateral surfaces of the PCM but during mitosis it relocalizes
CC       throughout the PCM and is found at the intercellular bridge. The MKSS
CC       protein is highly mobile and rapidly shuttles between the cytosol and
CC       centrosome.
CC   -!- TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues.
CC   -!- DOMAIN: The substrate-binding apical domain region is sufficient for
CC       centrosomal association.
CC   -!- DISEASE: McKusick-Kaufman syndrome (MKKS) [MIM:236700]: Autosomal
CC       recessive developmental disorder. It is characterized by
CC       hydrometrocolpos, postaxial polydactyly and congenital heart defects.
CC       {ECO:0000269|PubMed:10802661, ECO:0000269|PubMed:28753627}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Bardet-Biedl syndrome 6 (BBS6) [MIM:605231]: A syndrome
CC       characterized by usually severe pigmentary retinopathy, early-onset
CC       obesity, polydactyly, hypogenitalism, renal malformation and
CC       intellectual disability. Secondary features include diabetes mellitus,
CC       hypertension and congenital heart disease. Bardet-Biedl syndrome
CC       inheritance is autosomal recessive, but three mutated alleles (two at
CC       one locus, and a third at a second locus) may be required for clinical
CC       manifestation of some forms of the disease.
CC       {ECO:0000269|PubMed:10973238, ECO:0000269|PubMed:10973251,
CC       ECO:0000269|PubMed:11179009, ECO:0000269|PubMed:11567139,
CC       ECO:0000269|PubMed:12107442, ECO:0000269|PubMed:12677556,
CC       ECO:0000269|PubMed:12920096, ECO:0000269|PubMed:15666242,
CC       ECO:0000269|PubMed:15731008, ECO:0000269|PubMed:15770229,
CC       ECO:0000269|PubMed:18094050, ECO:0000269|PubMed:20080638,
CC       ECO:0000269|PubMed:21344540, ECO:0000269|PubMed:22152675,
CC       ECO:0000269|PubMed:26900326, ECO:0000269|PubMed:28753627,
CC       ECO:0000269|PubMed:28761321}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TCP-1 chaperonin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the MKKS gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="https://www.retina-international.org/files/sci-news/mkksmut.htm";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF221992; AAF73872.1; -; mRNA.
DR   EMBL; AF221993; AAF73873.1; -; mRNA.
DR   EMBL; AK291925; BAF84614.1; -; mRNA.
DR   EMBL; AL157427; CAB75652.1; -; mRNA.
DR   EMBL; AL034430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471133; EAX10344.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10345.1; -; Genomic_DNA.
DR   CCDS; CCDS13111.1; -.
DR   PIR; T46911; T46911.
DR   RefSeq; NP_061336.1; NM_018848.3.
DR   RefSeq; NP_740754.1; NM_170784.2.
DR   AlphaFoldDB; Q9NPJ1; -.
DR   SMR; Q9NPJ1; -.
DR   BioGRID; 113837; 15.
DR   CORUM; Q9NPJ1; -.
DR   DIP; DIP-60349N; -.
DR   IntAct; Q9NPJ1; 11.
DR   STRING; 9606.ENSP00000246062; -.
DR   GlyGen; Q9NPJ1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9NPJ1; -.
DR   PhosphoSitePlus; Q9NPJ1; -.
DR   BioMuta; MKKS; -.
DR   DMDM; 11133565; -.
DR   EPD; Q9NPJ1; -.
DR   MassIVE; Q9NPJ1; -.
DR   PaxDb; Q9NPJ1; -.
DR   PeptideAtlas; Q9NPJ1; -.
DR   ProteomicsDB; 82024; -.
DR   Antibodypedia; 24160; 158 antibodies from 24 providers.
DR   DNASU; 8195; -.
DR   Ensembl; ENST00000347364.7; ENSP00000246062.4; ENSG00000125863.20.
DR   Ensembl; ENST00000399054.6; ENSP00000382008.2; ENSG00000125863.20.
DR   Ensembl; ENST00000651692.1; ENSP00000498849.1; ENSG00000125863.20.
DR   GeneID; 8195; -.
DR   KEGG; hsa:8195; -.
DR   MANE-Select; ENST00000347364.7; ENSP00000246062.4; NM_170784.3; NP_740754.1.
DR   UCSC; uc002wnt.3; human.
DR   AGR; HGNC:7108; -.
DR   CTD; 8195; -.
DR   DisGeNET; 8195; -.
DR   GeneCards; MKKS; -.
DR   GeneReviews; MKKS; -.
DR   HGNC; HGNC:7108; MKKS.
DR   HPA; ENSG00000125863; Low tissue specificity.
DR   MalaCards; MKKS; -.
DR   MIM; 236700; phenotype.
DR   MIM; 604896; gene.
DR   MIM; 605231; phenotype.
DR   neXtProt; NX_Q9NPJ1; -.
DR   OpenTargets; ENSG00000125863; -.
DR   Orphanet; 110; Bardet-Biedl syndrome.
DR   Orphanet; 2473; McKusick-Kaufman syndrome.
DR   PharmGKB; PA30826; -.
DR   VEuPathDB; HostDB:ENSG00000125863; -.
DR   eggNOG; KOG0360; Eukaryota.
DR   GeneTree; ENSGT00390000007214; -.
DR   HOGENOM; CLU_478131_0_0_1; -.
DR   InParanoid; Q9NPJ1; -.
DR   OMA; LFVCQKV; -.
DR   OrthoDB; 3019878at2759; -.
DR   PhylomeDB; Q9NPJ1; -.
DR   TreeFam; TF329106; -.
DR   PathwayCommons; Q9NPJ1; -.
DR   Reactome; R-HSA-5620922; BBSome-mediated cargo-targeting to cilium.
DR   SignaLink; Q9NPJ1; -.
DR   BioGRID-ORCS; 8195; 12 hits in 1156 CRISPR screens.
DR   ChiTaRS; MKKS; human.
DR   GeneWiki; MKKS; -.
DR   GenomeRNAi; 8195; -.
DR   Pharos; Q9NPJ1; Tbio.
DR   PRO; PR:Q9NPJ1; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9NPJ1; protein.
DR   Bgee; ENSG00000125863; Expressed in middle temporal gyrus and 188 other tissues.
DR   Genevisible; Q9NPJ1; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:1902636; C:kinociliary basal body; IBA:GO_Central.
DR   GO; GO:0031514; C:motile cilium; ISS:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:MGI.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0014824; P:artery smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0048854; P:brain morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; ISS:BHF-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IBA:GO_Central.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0060027; P:convergent extension involved in gastrulation; ISS:BHF-UCL.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISS:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL.
DR   GO; GO:0032502; P:developmental process; IBA:GO_Central.
DR   GO; GO:0060324; P:face development; IEA:Ensembl.
DR   GO; GO:0045444; P:fat cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0008406; P:gonad development; TAS:ProtInc.
DR   GO; GO:0007507; P:heart development; TAS:ProtInc.
DR   GO; GO:0001947; P:heart looping; ISS:BHF-UCL.
DR   GO; GO:0021766; P:hippocampus development; ISS:BHF-UCL.
DR   GO; GO:0046907; P:intracellular transport; ISS:BHF-UCL.
DR   GO; GO:0032402; P:melanosome transport; ISS:BHF-UCL.
DR   GO; GO:0030837; P:negative regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0038108; P:negative regulation of appetite by leptin-mediated signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:1905515; P:non-motile cilium assembly; IEA:Ensembl.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; ISS:BHF-UCL.
DR   GO; GO:0051877; P:pigment granule aggregation in cell center; ISS:BHF-UCL.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   GO; GO:0060296; P:regulation of cilium beat frequency involved in ciliary motility; ISS:BHF-UCL.
DR   GO; GO:0051492; P:regulation of stress fiber assembly; IEA:Ensembl.
DR   GO; GO:0007608; P:sensory perception of smell; ISS:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; ISS:BHF-UCL.
DR   GO; GO:0007286; P:spermatid development; ISS:BHF-UCL.
DR   GO; GO:0021756; P:striatum development; ISS:BHF-UCL.
DR   GO; GO:0042311; P:vasodilation; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   Gene3D; 3.50.7.10; GroEL; 1.
DR   Gene3D; 1.10.560.10; GroEL-like equatorial domain; 1.
DR   Gene3D; 3.30.260.10; TCP-1-like chaperonin intermediate domain; 1.
DR   InterPro; IPR002423; Cpn60/GroEL/TCP-1.
DR   InterPro; IPR027409; GroEL-like_apical_dom_sf.
DR   InterPro; IPR027413; GROEL-like_equatorial_sf.
DR   InterPro; IPR028790; MKKS.
DR   InterPro; IPR027410; TCP-1-like_intermed_sf.
DR   PANTHER; PTHR46787; SYNDROMES PUTATIVE CHAPERONIN-RELATED; 1.
DR   PANTHER; PTHR46787:SF1; SYNDROMES PUTATIVE CHAPERONIN-RELATED; 1.
DR   Pfam; PF00118; Cpn60_TCP1; 1.
DR   SUPFAM; SSF52029; GroEL apical domain-like; 1.
DR   SUPFAM; SSF48592; GroEL equatorial domain-like; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Bardet-Biedl syndrome; Chaperone; Ciliopathy; Cytoplasm;
KW   Cytoskeleton; Disease variant; Intellectual disability; Nucleotide-binding;
KW   Nucleus; Obesity; Reference proteome; Sensory transduction; Vision.
FT   CHAIN           1..570
FT                   /note="Molecular chaperone MKKS"
FT                   /id="PRO_0000128415"
FT   REGION          198..370
FT                   /note="Substrate-binding apical domain"
FT   BINDING         192..199
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   VARIANT         32
FT                   /note="I -> M (in BBS6)"
FT                   /evidence="ECO:0000269|PubMed:11179009"
FT                   /id="VAR_017035"
FT   VARIANT         37
FT                   /note="Y -> C (in MKKS and BBS6; causes both increased MKKS
FT                   protein degradation and reduced solubility relative to
FT                   wild-type and Tyr-84 mutant; the mutant is immobilized at
FT                   the centrosome even in the absence of proteasome
FT                   inhibition; the mutant is also highly polyubiquitinated; no
FT                   effect on import to the nucleus; dbSNP:rs74315396)"
FT                   /evidence="ECO:0000269|PubMed:10802661,
FT                   ECO:0000269|PubMed:10973251, ECO:0000269|PubMed:11567139,
FT                   ECO:0000269|PubMed:18094050, ECO:0000269|PubMed:20080638,
FT                   ECO:0000269|PubMed:28753627"
FT                   /id="VAR_009864"
FT   VARIANT         40..570
FT                   /note="Missing (in BBS6)"
FT                   /evidence="ECO:0000269|PubMed:28761321"
FT                   /id="VAR_080223"
FT   VARIANT         41
FT                   /note="G -> R (in BBS6; dbSNP:rs766132697)"
FT                   /evidence="ECO:0000269|PubMed:21344540"
FT                   /id="VAR_066262"
FT   VARIANT         49
FT                   /note="G -> V (in dbSNP:rs528833454)"
FT                   /evidence="ECO:0000269|PubMed:10802661"
FT                   /id="VAR_009865"
FT   VARIANT         52
FT                   /note="G -> D (in BBS6; fails to associate with centrosome;
FT                   dbSNP:rs28937875)"
FT                   /evidence="ECO:0000269|PubMed:10973238,
FT                   ECO:0000269|PubMed:15731008, ECO:0000269|PubMed:20080638"
FT                   /id="VAR_009882"
FT   VARIANT         57
FT                   /note="T -> A (in BBS6; found in a patient also carrying
FT                   A-155 in TMEM237; causes both increased MKKS protein
FT                   degradation and reduced solubility relative to wild-type
FT                   and Y-84 mutant; greatly reduces the ability to interact
FT                   with BBS12; dbSNP:rs74315399)"
FT                   /evidence="ECO:0000269|PubMed:10973251,
FT                   ECO:0000269|PubMed:11179009, ECO:0000269|PubMed:18094050,
FT                   ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:22152675"
FT                   /id="VAR_009883"
FT   VARIANT         84
FT                   /note="H -> Y (in MKKS; associated with S-242; decreased
FT                   interaction with BBS12; no effect on ciliogenesis; disrupts
FT                   import to the nucleus; no effect on interaction with
FT                   SMARCC1; may affect modulation of SMARCC1 subcellular
FT                   location; dbSNP:rs281797258)"
FT                   /evidence="ECO:0000269|PubMed:10802661,
FT                   ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:28753627"
FT                   /id="VAR_009866"
FT   VARIANT         99
FT                   /note="C -> R (in BBS6; dbSNP:rs1297985227)"
FT                   /evidence="ECO:0000269|PubMed:21344540"
FT                   /id="VAR_066263"
FT   VARIANT         155
FT                   /note="R -> L (in BBS6; increases MKKS protein degradation;
FT                   localizes properly to the centrosome; dbSNP:rs138111422)"
FT                   /evidence="ECO:0000269|PubMed:12107442,
FT                   ECO:0000269|PubMed:15731008"
FT                   /id="VAR_017040"
FT   VARIANT         181
FT                   /note="A -> P (in BBS6)"
FT                   /evidence="ECO:0000269|PubMed:12920096"
FT                   /id="VAR_038898"
FT   VARIANT         236
FT                   /note="S -> P (in BBS6)"
FT                   /evidence="ECO:0000269|PubMed:11179009,
FT                   ECO:0000269|PubMed:12677556, ECO:0000269|PubMed:20080638"
FT                   /id="VAR_017036"
FT   VARIANT         237
FT                   /note="T -> A (in BBS6; dbSNP:rs760185677)"
FT                   /evidence="ECO:0000269|PubMed:15770229"
FT                   /id="VAR_038899"
FT   VARIANT         237
FT                   /note="T -> P (in BBS6)"
FT                   /evidence="ECO:0000269|PubMed:15666242,
FT                   ECO:0000269|PubMed:15770229"
FT                   /id="VAR_038900"
FT   VARIANT         242
FT                   /note="A -> S (in MKKS and BBS6; associated with Y-84 in
FT                   MKKS; unknown pathological significance; increases MKKS
FT                   protein degradation; no effect on ciliogenesis; disrupts
FT                   import to the nucleus; no effect on interaction with
FT                   SMARCC1; may affect modulation of SMARCC1 subcellular
FT                   location; dbSNP:rs74315394)"
FT                   /evidence="ECO:0000269|PubMed:10802661,
FT                   ECO:0000269|PubMed:11179009, ECO:0000269|PubMed:11567139,
FT                   ECO:0000269|PubMed:12107442, ECO:0000269|PubMed:15483080,
FT                   ECO:0000269|PubMed:18094050, ECO:0000269|PubMed:20120035,
FT                   ECO:0000269|PubMed:28753627"
FT                   /id="VAR_009867"
FT   VARIANT         277
FT                   /note="L -> P (in BBS6; moderately affects interaction with
FT                   BBS2; greatly reduces the ability to interact with BBS12;
FT                   dbSNP:rs74315398)"
FT                   /evidence="ECO:0000269|PubMed:10973251,
FT                   ECO:0000269|PubMed:20080638"
FT                   /id="VAR_009884"
FT   VARIANT         286
FT                   /note="D -> A (in BBS6; fails to associate with
FT                   centrosome)"
FT                   /evidence="ECO:0000269|PubMed:11179009,
FT                   ECO:0000269|PubMed:15731008"
FT                   /id="VAR_017037"
FT   VARIANT         299
FT                   /note="P -> L (in BBS6; dbSNP:rs756083063)"
FT                   /evidence="ECO:0000269|PubMed:21344540"
FT                   /id="VAR_066264"
FT   VARIANT         325
FT                   /note="T -> P (has a modifier effect on BBS; causes a
FT                   mislocalization of the protein; fails to associate with
FT                   centrosome; dbSNP:rs137853156)"
FT                   /evidence="ECO:0000269|PubMed:12677556,
FT                   ECO:0000269|PubMed:12837689, ECO:0000269|PubMed:15731008"
FT                   /id="VAR_038901"
FT   VARIANT         339
FT                   /note="I -> V (in dbSNP:rs137853909)"
FT                   /evidence="ECO:0000269|PubMed:12107442,
FT                   ECO:0000269|PubMed:15666242, ECO:0000269|PubMed:15770229"
FT                   /id="VAR_017041"
FT   VARIANT         345
FT                   /note="G -> E (in BBS6; increases MKKS protein degradation;
FT                   fails to associate with centrosome; the mutant is highly
FT                   polyubiquitinated and rapidly degraded by the
FT                   ubiquitin-proteasome protein degradation pathway;
FT                   dbSNP:rs779116830)"
FT                   /evidence="ECO:0000269|PubMed:12107442,
FT                   ECO:0000269|PubMed:15731008, ECO:0000269|PubMed:18094050"
FT                   /id="VAR_017042"
FT   VARIANT         395
FT                   /note="H -> R (in BBS6; atypical mild phenotype consisting
FT                   of retinitis pigmentosa and polydactyly without other signs
FT                   of Bardet-Biedl syndrome; results in decreased interaction
FT                   with BBS12; dbSNP:rs912923677)"
FT                   /evidence="ECO:0000269|PubMed:26900326"
FT                   /id="VAR_077208"
FT   VARIANT         460
FT                   /note="S -> P (in BBS6)"
FT                   /evidence="ECO:0000269|PubMed:15666242"
FT                   /id="VAR_038902"
FT   VARIANT         488
FT                   /note="A -> T (in a patient with Bardet-Biedl syndrome
FT                   compound heterozygote for mutations in BBS12; uncertain
FT                   pathological role; dbSNP:rs61734546)"
FT                   /evidence="ECO:0000269|PubMed:21344540"
FT                   /id="VAR_066265"
FT   VARIANT         492
FT                   /note="D -> N (in BBS6; unknown pathological significance;
FT                   dbSNP:rs142327258)"
FT                   /evidence="ECO:0000269|PubMed:12920096"
FT                   /id="VAR_038903"
FT   VARIANT         499
FT                   /note="C -> S (in BBS6; causes both increased MKKS protein
FT                   degradation and reduced solubility relative to wild-type
FT                   and Tyr-84 mutant; localizes properly to the centrosome;
FT                   dbSNP:rs281797259 and dbSNP:rs137853155)"
FT                   /evidence="ECO:0000269|PubMed:11179009,
FT                   ECO:0000269|PubMed:11567139, ECO:0000269|PubMed:15731008,
FT                   ECO:0000269|PubMed:18094050"
FT                   /id="VAR_013161"
FT   VARIANT         511
FT                   /note="S -> A (in BBS6)"
FT                   /evidence="ECO:0000269|PubMed:11179009"
FT                   /id="VAR_017038"
FT   VARIANT         517
FT                   /note="R -> C (in dbSNP:rs1547)"
FT                   /evidence="ECO:0000269|PubMed:10802661,
FT                   ECO:0000269|PubMed:15483080, ECO:0000269|PubMed:15666242,
FT                   ECO:0000269|PubMed:15770229"
FT                   /id="VAR_009868"
FT   VARIANT         518
FT                   /note="R -> H (in BBS6; dbSNP:rs149051148)"
FT                   /evidence="ECO:0000269|PubMed:11179009"
FT                   /id="VAR_017039"
FT   VARIANT         532
FT                   /note="G -> V (in dbSNP:rs1545)"
FT                   /evidence="ECO:0000269|PubMed:15483080,
FT                   ECO:0000269|PubMed:15666242, ECO:0000269|PubMed:15770229"
FT                   /id="VAR_009869"
FT   MUTAGEN         454
FT                   /note="L->P: No effect on import to the nucleus."
FT                   /evidence="ECO:0000269|PubMed:28753627"
SQ   SEQUENCE   570 AA;  62342 MW;  14BA57FF8AEA0AF7 CRC64;
     MSRLEAKKPS LCKSEPLTTE RVRTTLSVLK RIVTSCYGPS GRLKQLHNGF GGYVCTTSQS
     SALLSHLLVT HPILKILTAS IQNHVSSFSD CGLFTAILCC NLIENVQRLG LTPTTVIRLN
     KHLLSLCISY LKSETCGCRI PVDFSSTQIL LCLVRSILTS KPACMLTRKE TEHVSALILR
     AFLLTIPENA EGHIILGKSL IVPLKGQRVI DSTVLPGILI EMSEVQLMRL LPIKKSTALK
     VALFCTTLSG DTSDTGEGTV VVSYGVSLEN AVLDQLLNLG RQLISDHVDL VLCQKVIHPS
     LKQFLNMHRI IAIDRIGVTL MEPLTKMTGT QPIGSLGSIC PNSYGSVKDV CTAKFGSKHF
     FHLIPNEATI CSLLLCNRND TAWDELKLTC QTALHVLQLT LKEPWALLGG GCTETHLAAY
     IRHKTHNDPE SILKDDECTQ TELQLIAEAF CSALESVVGS LEHDGGEILT DMKYGHLWSV
     QADSPCVANW PDLLSQCGCG LYNSQEELNW SFLRSTRRPF VPQSCLPHEA VGSASNLTLD
     CLTAKLSGLQ VAVETANLIL DLSYVIEDKN
//
